Natural Alternatives International (NASDAQ:NAII) Releases Quarterly Earnings Results

Natural Alternatives International (NASDAQ:NAII) posted its earnings results on Wednesday. The company reported ($0.05) EPS for the quarter, FiscalAI reports. The firm had revenue of $37.73 million for the quarter. Natural Alternatives International had a negative net margin of 10.45% and a negative return on equity of 9.69%.

Natural Alternatives International Price Performance

Shares of NASDAQ NAII opened at $2.81 on Thursday. Natural Alternatives International has a 52 week low of $2.57 and a 52 week high of $4.70. The business’s 50 day moving average price is $2.94 and its 200 day moving average price is $3.27. The company has a quick ratio of 1.19, a current ratio of 2.06 and a debt-to-equity ratio of 0.13. The firm has a market cap of $17.36 million, a P/E ratio of -1.24 and a beta of 0.54.

Analyst Ratings Changes

Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Natural Alternatives International in a research report on Wednesday, October 8th. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, Natural Alternatives International presently has an average rating of “Sell”.

Institutional Trading of Natural Alternatives International

A hedge fund recently bought a new stake in Natural Alternatives International stock. EP Wealth Advisors LLC acquired a new position in Natural Alternatives International, Inc. (NASDAQ:NAII) during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 14,000 shares of the company’s stock, valued at approximately $48,000. EP Wealth Advisors LLC owned 0.23% of Natural Alternatives International at the end of the most recent reporting period. Institutional investors and hedge funds own 32.40% of the company’s stock.

About Natural Alternatives International

Natural Alternatives International, Inc engages in formulating, manufacturing, and marketing nutritional supplements in the United States, Europe, Australia, Asia, Mexico, and Canada. The company operates in two segments, Private-Label Contract Manufacturing, and Patent and Trademark Licensing. It offers private-label contract manufacturing services to companies that market and distribute vitamins, minerals, herbal, and other nutritional supplements, as well as other health care products.